Literature DB >> 11192863

Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors.

A A Morris, S V Baudouin, M H Snow.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11192863     DOI: 10.1097/00002030-200101050-00027

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

Review 1.  Mitochondrial toxicity and HIV therapy.

Authors:  A J White
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

Review 2.  HIV-associated renal disorders: recent insights into pathogenesis and treatment.

Authors:  Ruth Berggren; Vecihi Batuman
Journal:  Curr HIV/AIDS Rep       Date:  2005-08       Impact factor: 5.071

Review 3.  Expert opinion on pharmacotherapy of kidney disease in HIV-infected patients.

Authors:  Zygimantas C Alsauskas; Raj Kiran Medapalli; Michael J Ross
Journal:  Expert Opin Pharmacother       Date:  2011-01-21       Impact factor: 3.889

Review 4.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 5.  The nephrotoxic effects of HAART.

Authors:  Hassane Izzedine; Marianne Harris; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

6.  Clinical monitoring and correlates of nephropathy in SIV-infected macaques during high-dose antiretroviral therapy.

Authors:  Brigitte E Sanders-Beer; Yvette Y Spano; Dawn Golighty; Abigail Lara; Diane Hebblewaite; Lourdes Nieves-Duran; Lowrey Rhodes; Keith G Mansfield
Journal:  AIDS Res Ther       Date:  2011-01-21       Impact factor: 2.250

Review 7.  Antimicrobial-induced Electrolyte and Acid-Base Disturbances.

Authors:  Yang Wook Kim
Journal:  Electrolyte Blood Press       Date:  2007-12-31

Review 8.  Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.

Authors:  Milena M McLaughlin; Aimee J Guerrero; Andrew Merker
Journal:  Drugs Context       Date:  2018-03-21

9.  Efavirenz reduces renal excretion of lamivudine in rats by inhibiting organic cation transporters (OCT, Oct) and multidrug and toxin extrusion proteins (MATE, Mate).

Authors:  Martina Ceckova; Josef Reznicek; Birgit Deutsch; Martin F Fromm; Frantisek Staud
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.